New drug duo targets tough bladder cancer
NCT ID NCT04004442
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This early-stage study tests the safety of combining two drugs, avelumab and AVB-S6-500, in people with advanced urothelial carcinoma (bladder cancer) that has spread or cannot be removed by surgery. The 19 participants have already tried at least one standard chemotherapy. The goal is to see if the combination is safe and can help control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.